Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 11 | 2023 | 372 | 2.710 |
Why?
|
| Suicide | 6 | 2023 | 124 | 1.680 |
Why?
|
| Analgesics, Opioid | 14 | 2022 | 243 | 1.500 |
Why?
|
| Suicide, Attempted | 10 | 2022 | 99 | 1.400 |
Why?
|
| Depression | 6 | 2022 | 504 | 1.270 |
Why?
|
| Chronic Pain | 12 | 2017 | 127 | 1.190 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 327 | 1.180 |
Why?
|
| Humans | 67 | 2023 | 17707 | 1.040 |
Why?
|
| Smoking Cessation | 4 | 2014 | 193 | 0.960 |
Why?
|
| Internet | 4 | 2014 | 229 | 0.950 |
Why?
|
| Precision Medicine | 2 | 2022 | 28 | 0.950 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 46 | 0.900 |
Why?
|
| Suicidal Ideation | 6 | 2022 | 100 | 0.810 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2020 | 61 | 0.810 |
Why?
|
| Models, Statistical | 5 | 2021 | 177 | 0.790 |
Why?
|
| Labetalol | 1 | 2022 | 9 | 0.790 |
Why?
|
| Confidentiality | 1 | 2022 | 25 | 0.780 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 36 | 0.770 |
Why?
|
| Middle Aged | 43 | 2022 | 7976 | 0.750 |
Why?
|
| Antidepressive Agents | 3 | 2021 | 153 | 0.740 |
Why?
|
| Schizophrenia | 3 | 2016 | 75 | 0.730 |
Why?
|
| Risk Assessment | 6 | 2021 | 1106 | 0.730 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 49 | 0.730 |
Why?
|
| Female | 46 | 2022 | 12729 | 0.700 |
Why?
|
| Premature Birth | 1 | 2022 | 141 | 0.690 |
Why?
|
| Male | 43 | 2022 | 10094 | 0.690 |
Why?
|
| Opioid-Related Disorders | 9 | 2017 | 165 | 0.690 |
Why?
|
| Aged | 34 | 2022 | 6150 | 0.660 |
Why?
|
| Mental Health | 5 | 2023 | 161 | 0.660 |
Why?
|
| Drug Prescriptions | 4 | 2020 | 151 | 0.650 |
Why?
|
| Adult | 34 | 2022 | 7658 | 0.630 |
Why?
|
| Outcome Assessment (Health Care) | 3 | 2017 | 227 | 0.620 |
Why?
|
| Electronic Health Records | 9 | 2021 | 694 | 0.600 |
Why?
|
| Self-Injurious Behavior | 3 | 2022 | 45 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 75 | 0.570 |
Why?
|
| Computer Simulation | 3 | 2017 | 81 | 0.540 |
Why?
|
| Treatment Outcome | 11 | 2022 | 1254 | 0.530 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 717 | 0.530 |
Why?
|
| Propensity Score | 1 | 2017 | 85 | 0.530 |
Why?
|
| Process Assessment (Health Care) | 1 | 2016 | 23 | 0.520 |
Why?
|
| Patient Dropouts | 1 | 2016 | 22 | 0.520 |
Why?
|
| Bias | 3 | 2017 | 103 | 0.520 |
Why?
|
| Young Adult | 16 | 2020 | 2450 | 0.470 |
Why?
|
| Alcoholism | 4 | 2019 | 332 | 0.430 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 324 | 0.400 |
Why?
|
| Writing | 1 | 2012 | 10 | 0.400 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 12 | 0.400 |
Why?
|
| Risk Factors | 10 | 2023 | 3367 | 0.390 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2020 | 531 | 0.380 |
Why?
|
| Sample Size | 2 | 2023 | 29 | 0.380 |
Why?
|
| Odds Ratio | 3 | 2017 | 670 | 0.370 |
Why?
|
| Back Pain | 4 | 2022 | 33 | 0.370 |
Why?
|
| Primary Health Care | 6 | 2019 | 756 | 0.360 |
Why?
|
| Adolescent | 12 | 2020 | 3671 | 0.360 |
Why?
|
| Depressive Disorder | 3 | 2017 | 220 | 0.350 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 4 | 2015 | 39 | 0.340 |
Why?
|
| Osteoarthritis | 3 | 2014 | 15 | 0.330 |
Why?
|
| Surveys and Questionnaires | 10 | 2020 | 1322 | 0.320 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 80 | 0.310 |
Why?
|
| Exercise | 1 | 2013 | 496 | 0.290 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 1927 | 0.290 |
Why?
|
| Cohort Studies | 12 | 2021 | 2589 | 0.290 |
Why?
|
| Risk Reduction Behavior | 4 | 2017 | 108 | 0.290 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 123 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 596 | 0.280 |
Why?
|
| Data Accuracy | 2 | 2019 | 27 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 128 | 0.280 |
Why?
|
| Psychotherapy | 2 | 2017 | 57 | 0.260 |
Why?
|
| Mental Health Services | 2 | 2019 | 154 | 0.260 |
Why?
|
| Retrospective Studies | 7 | 2022 | 2471 | 0.260 |
Why?
|
| Community Mental Health Services | 2 | 2016 | 32 | 0.260 |
Why?
|
| United States | 11 | 2022 | 3914 | 0.250 |
Why?
|
| Hypertension | 2 | 2021 | 498 | 0.250 |
Why?
|
| Motivation | 3 | 2014 | 130 | 0.230 |
Why?
|
| Substance Abuse Detection | 2 | 2014 | 17 | 0.220 |
Why?
|
| Occupations | 2 | 2014 | 16 | 0.220 |
Why?
|
| Outpatients | 3 | 2019 | 107 | 0.220 |
Why?
|
| Logistic Models | 6 | 2019 | 918 | 0.210 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 159 | 0.210 |
Why?
|
| Occupational Exposure | 2 | 2014 | 67 | 0.210 |
Why?
|
| Machine Learning | 2 | 2022 | 47 | 0.210 |
Why?
|
| Counseling | 2 | 2015 | 187 | 0.210 |
Why?
|
| Methyldopa | 1 | 2022 | 6 | 0.200 |
Why?
|
| Nifedipine | 1 | 2022 | 7 | 0.200 |
Why?
|
| Patient Acuity | 1 | 2022 | 7 | 0.200 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 85 | 0.200 |
Why?
|
| Decision Making | 2 | 2014 | 182 | 0.190 |
Why?
|
| Patient Care | 1 | 2022 | 35 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 448 | 0.190 |
Why?
|
| Informed Consent | 1 | 2021 | 20 | 0.190 |
Why?
|
| Disability Evaluation | 2 | 2013 | 46 | 0.180 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2021 | 71 | 0.180 |
Why?
|
| Health Services | 1 | 2022 | 114 | 0.180 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 162 | 0.180 |
Why?
|
| Medicaid | 1 | 2022 | 188 | 0.180 |
Why?
|
| Self Report | 6 | 2019 | 252 | 0.170 |
Why?
|
| Pregnancy | 3 | 2022 | 1535 | 0.170 |
Why?
|
| HIV Infections | 2 | 2017 | 704 | 0.170 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 53 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 86 | 0.170 |
Why?
|
| Eligibility Determination | 1 | 2020 | 12 | 0.170 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 123 | 0.170 |
Why?
|
| Pain | 3 | 2017 | 79 | 0.170 |
Why?
|
| Washington | 5 | 2020 | 382 | 0.170 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 361 | 0.170 |
Why?
|
| Models, Psychological | 1 | 2019 | 23 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 27 | 0.160 |
Why?
|
| Sleep | 3 | 2014 | 58 | 0.160 |
Why?
|
| Infant, Newborn | 1 | 2022 | 857 | 0.160 |
Why?
|
| Veterans | 2 | 2017 | 137 | 0.150 |
Why?
|
| Infant | 1 | 2022 | 1199 | 0.150 |
Why?
|
| Prescription Drug Misuse | 1 | 2017 | 9 | 0.140 |
Why?
|
| Models, Theoretical | 2 | 2014 | 68 | 0.140 |
Why?
|
| Time Factors | 6 | 2016 | 1095 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2016 | 296 | 0.140 |
Why?
|
| Biometry | 1 | 2017 | 13 | 0.140 |
Why?
|
| Minority Groups | 1 | 2017 | 101 | 0.140 |
Why?
|
| Fibromyalgia | 1 | 2016 | 4 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2016 | 15 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 1218 | 0.130 |
Why?
|
| Vehicle Emissions | 2 | 2014 | 23 | 0.130 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 42 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2015 | 53 | 0.120 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 100 | 0.120 |
Why?
|
| European Continental Ancestry Group | 1 | 2017 | 523 | 0.120 |
Why?
|
| Documentation | 1 | 2015 | 42 | 0.120 |
Why?
|
| Cause of Death | 1 | 2016 | 181 | 0.120 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 26 | 0.120 |
Why?
|
| Life Style | 2 | 2014 | 332 | 0.120 |
Why?
|
| Sex Factors | 2 | 2014 | 639 | 0.110 |
Why?
|
| Fatigue | 1 | 2014 | 34 | 0.110 |
Why?
|
| Urinalysis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 49 | 0.110 |
Why?
|
| Mass Screening | 1 | 2019 | 667 | 0.110 |
Why?
|
| Patients | 1 | 2014 | 35 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 41 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2014 | 51 | 0.110 |
Why?
|
| Smoking | 2 | 2014 | 483 | 0.110 |
Why?
|
| Arthralgia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2016 | 245 | 0.110 |
Why?
|
| Patient Selection | 1 | 2014 | 190 | 0.100 |
Why?
|
| Mortality | 1 | 2013 | 118 | 0.100 |
Why?
|
| Social Support | 1 | 2013 | 204 | 0.100 |
Why?
|
| Risk | 3 | 2019 | 517 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2017 | 120 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1 | 0.090 |
Why?
|
| Patella | 1 | 2010 | 1 | 0.090 |
Why?
|
| Knee Joint | 1 | 2010 | 2 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 11 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 355 | 0.090 |
Why?
|
| Pain Management | 3 | 2015 | 57 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2010 | 75 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 199 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2009 | 53 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 14 | 0.080 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 28 | 0.080 |
Why?
|
| Drug Monitoring | 2 | 2021 | 21 | 0.070 |
Why?
|
| Prevalence | 3 | 2017 | 882 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 299 | 0.070 |
Why?
|
| Obesity | 2 | 2010 | 841 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2017 | 1287 | 0.060 |
Why?
|
| Australia | 3 | 2009 | 23 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 160 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 483 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 314 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 613 | 0.050 |
Why?
|
| Educational Status | 2 | 2014 | 198 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 755 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 37 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 18 | 0.050 |
Why?
|
| Age Distribution | 2 | 2015 | 246 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 10 | 0.050 |
Why?
|
| Citalopram | 1 | 2021 | 14 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 28 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2021 | 26 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2021 | 13 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2022 | 65 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1117 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 216 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 74 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 311 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 237 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 590 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 377 | 0.040 |
Why?
|
| Anticipation, Psychological | 1 | 2017 | 1 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 1269 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 45 | 0.030 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2016 | 25 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 46 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2016 | 88 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2016 | 21 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 154 | 0.030 |
Why?
|
| Colorado | 1 | 2016 | 164 | 0.030 |
Why?
|
| Control Groups | 1 | 2015 | 2 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 111 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 805 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 21 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 229 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 88 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 189 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 301 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 124 | 0.030 |
Why?
|
| Air Pollutants, Occupational | 1 | 2014 | 16 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2014 | 29 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 260 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 161 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 10 | 0.030 |
Why?
|
| Attitude | 1 | 2014 | 30 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 159 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 77 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2014 | 237 | 0.030 |
Why?
|
| Catastrophization | 1 | 2013 | 4 | 0.030 |
Why?
|
| Fear | 1 | 2013 | 14 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2013 | 26 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2014 | 265 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 90 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 37 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 204 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2012 | 68 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 371 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 140 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1322 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 3 | 0.020 |
Why?
|
| Anthropometry | 1 | 2010 | 66 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 626 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 97 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 107 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 266 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2009 | 28 | 0.020 |
Why?
|
| Parity | 1 | 2009 | 74 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 710 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 561 | 0.020 |
Why?
|
| Overweight | 1 | 2009 | 270 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 970 | 0.020 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->